Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staphylococcal Infections | 85 | 2024 | 556 | 10.930 |
Why?
|
Staphylococcus aureus | 65 | 2024 | 458 | 8.890 |
Why?
|
Pneumococcal Infections | 51 | 2022 | 275 | 6.780 |
Why?
|
Community-Acquired Infections | 45 | 2024 | 240 | 6.700 |
Why?
|
Streptococcus pneumoniae | 64 | 2023 | 374 | 5.820 |
Why?
|
Anti-Bacterial Agents | 119 | 2024 | 2426 | 5.210 |
Why?
|
Osteomyelitis | 27 | 2024 | 203 | 4.590 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 36 | 2024 | 220 | 4.490 |
Why?
|
Bacteremia | 39 | 2024 | 405 | 3.850 |
Why?
|
Microbial Sensitivity Tests | 71 | 2024 | 794 | 3.430 |
Why?
|
Pneumococcal Vaccines | 21 | 2023 | 168 | 2.720 |
Why?
|
Methicillin Resistance | 22 | 2017 | 118 | 2.350 |
Why?
|
Infant | 162 | 2024 | 12465 | 2.240 |
Why?
|
Soft Tissue Infections | 11 | 2024 | 84 | 2.240 |
Why?
|
Child, Preschool | 173 | 2024 | 13993 | 2.240 |
Why?
|
Meningitis, Bacterial | 18 | 2022 | 93 | 2.150 |
Why?
|
Child | 203 | 2025 | 24349 | 2.130 |
Why?
|
Hospitals, Pediatric | 19 | 2024 | 769 | 2.080 |
Why?
|
Penicillins | 16 | 2024 | 154 | 1.880 |
Why?
|
Arthritis, Infectious | 10 | 2019 | 59 | 1.830 |
Why?
|
Cross Infection | 10 | 2019 | 323 | 1.780 |
Why?
|
Penicillin Resistance | 23 | 2024 | 80 | 1.580 |
Why?
|
Meningococcal Infections | 4 | 2019 | 19 | 1.580 |
Why?
|
Vancomycin | 20 | 2023 | 219 | 1.430 |
Why?
|
Otitis Media | 16 | 2024 | 84 | 1.430 |
Why?
|
Haemophilus influenzae | 31 | 2021 | 130 | 1.420 |
Why?
|
Meningitis, Pneumococcal | 17 | 2015 | 41 | 1.400 |
Why?
|
Oxazolidinones | 10 | 2010 | 33 | 1.390 |
Why?
|
Acetamides | 10 | 2010 | 47 | 1.370 |
Why?
|
Humans | 308 | 2025 | 124161 | 1.350 |
Why?
|
Neisseria meningitidis, Serogroup B | 3 | 2019 | 7 | 1.310 |
Why?
|
Meningitis, Haemophilus | 19 | 2009 | 34 | 1.240 |
Why?
|
Communicable Diseases | 3 | 2022 | 160 | 1.170 |
Why?
|
Mastoiditis | 4 | 2024 | 33 | 1.150 |
Why?
|
Population Surveillance | 8 | 2018 | 388 | 1.150 |
Why?
|
Meningococcal Vaccines | 4 | 2018 | 30 | 1.140 |
Why?
|
Serotyping | 26 | 2018 | 178 | 1.140 |
Why?
|
Coinfection | 3 | 2021 | 171 | 1.130 |
Why?
|
Anti-Infective Agents | 10 | 2023 | 264 | 1.130 |
Why?
|
Cat-Scratch Disease | 5 | 2013 | 33 | 1.110 |
Why?
|
Staphylococcal Skin Infections | 6 | 2024 | 39 | 1.100 |
Why?
|
Adolescent | 89 | 2024 | 19240 | 1.080 |
Why?
|
Meningitis | 21 | 2017 | 98 | 1.030 |
Why?
|
Infant, Newborn | 72 | 2024 | 8188 | 1.030 |
Why?
|
Male | 153 | 2024 | 60995 | 1.010 |
Why?
|
Gram-Positive Bacterial Infections | 7 | 2019 | 76 | 1.010 |
Why?
|
Haemophilus Infections | 18 | 2021 | 91 | 0.990 |
Why?
|
Ceftriaxone | 15 | 2016 | 67 | 0.990 |
Why?
|
Texas | 29 | 2024 | 3578 | 0.980 |
Why?
|
Pneumonia, Pneumococcal | 7 | 2023 | 82 | 0.980 |
Why?
|
Leukocidins | 8 | 2018 | 37 | 0.980 |
Why?
|
Exotoxins | 8 | 2018 | 44 | 0.980 |
Why?
|
Sinusitis | 6 | 2024 | 117 | 0.940 |
Why?
|
Bacterial Infections | 14 | 2019 | 310 | 0.940 |
Why?
|
Cephalosporins | 13 | 2022 | 137 | 0.940 |
Why?
|
Female | 144 | 2024 | 66270 | 0.930 |
Why?
|
Drug Resistance, Bacterial | 16 | 2017 | 364 | 0.930 |
Why?
|
Streptococcal Infections | 11 | 2024 | 243 | 0.910 |
Why?
|
Clindamycin | 9 | 2022 | 41 | 0.870 |
Why?
|
Dexamethasone | 12 | 2009 | 272 | 0.820 |
Why?
|
Retrospective Studies | 56 | 2024 | 16280 | 0.810 |
Why?
|
Anti-Infective Agents, Local | 4 | 2019 | 70 | 0.790 |
Why?
|
Serogroup | 7 | 2019 | 58 | 0.770 |
Why?
|
Bacterial Toxins | 8 | 2018 | 175 | 0.730 |
Why?
|
Antibodies, Bacterial | 11 | 2012 | 388 | 0.720 |
Why?
|
Electrophoresis, Gel, Pulsed-Field | 10 | 2019 | 92 | 0.720 |
Why?
|
Splenic Diseases | 4 | 2008 | 32 | 0.700 |
Why?
|
Prospective Studies | 34 | 2024 | 6117 | 0.700 |
Why?
|
Liver Abscess | 5 | 2016 | 12 | 0.680 |
Why?
|
Multilocus Sequence Typing | 9 | 2024 | 56 | 0.680 |
Why?
|
Histiocytosis, Non-Langerhans-Cell | 3 | 2004 | 15 | 0.650 |
Why?
|
Chlorhexidine | 3 | 2017 | 45 | 0.640 |
Why?
|
Pneumonia | 5 | 2018 | 324 | 0.640 |
Why?
|
Head | 1 | 2019 | 103 | 0.620 |
Why?
|
Neck | 1 | 2019 | 136 | 0.610 |
Why?
|
Bacterial Typing Techniques | 7 | 2021 | 102 | 0.590 |
Why?
|
Fever | 7 | 2015 | 294 | 0.580 |
Why?
|
Vaccines, Conjugate | 8 | 2023 | 78 | 0.570 |
Why?
|
Meningitis, Meningococcal | 7 | 2013 | 14 | 0.570 |
Why?
|
Rifampin | 8 | 2008 | 129 | 0.560 |
Why?
|
Immunocompromised Host | 6 | 2019 | 294 | 0.560 |
Why?
|
Trimethoprim, Sulfamethoxazole Drug Combination | 2 | 2009 | 42 | 0.550 |
Why?
|
Gram-Positive Bacteria | 4 | 2009 | 46 | 0.540 |
Why?
|
United States | 36 | 2025 | 10861 | 0.540 |
Why?
|
Treatment Outcome | 33 | 2022 | 12289 | 0.530 |
Why?
|
Ear, Middle | 3 | 2015 | 25 | 0.530 |
Why?
|
Sodium Hypochlorite | 2 | 2013 | 7 | 0.520 |
Why?
|
Baths | 2 | 2013 | 16 | 0.520 |
Why?
|
Haemophilus Vaccines | 6 | 1997 | 30 | 0.510 |
Why?
|
Bartonella henselae | 2 | 2008 | 20 | 0.510 |
Why?
|
Drug Therapy, Combination | 18 | 2009 | 1162 | 0.500 |
Why?
|
Acute Disease | 14 | 2024 | 1107 | 0.500 |
Why?
|
Retropharyngeal Abscess | 1 | 2015 | 7 | 0.490 |
Why?
|
Mastoid | 1 | 2015 | 24 | 0.480 |
Why?
|
Neutrophils | 8 | 2013 | 381 | 0.460 |
Why?
|
Methicillin | 11 | 2023 | 43 | 0.460 |
Why?
|
Bacteria | 6 | 2019 | 484 | 0.460 |
Why?
|
Cellulitis | 5 | 2011 | 63 | 0.440 |
Why?
|
Vaccines | 1 | 2019 | 365 | 0.440 |
Why?
|
Disinfection | 1 | 2013 | 26 | 0.440 |
Why?
|
Drug Resistance, Microbial | 14 | 2004 | 193 | 0.440 |
Why?
|
Hygiene | 1 | 2013 | 26 | 0.440 |
Why?
|
Disinfectants | 1 | 2013 | 25 | 0.430 |
Why?
|
Retinitis | 1 | 2013 | 17 | 0.430 |
Why?
|
Genital Diseases, Female | 1 | 2013 | 28 | 0.420 |
Why?
|
Brain Abscess | 6 | 2024 | 56 | 0.420 |
Why?
|
Influenza, Human | 1 | 2019 | 658 | 0.420 |
Why?
|
Carrier State | 2 | 2011 | 77 | 0.410 |
Why?
|
Incidence | 15 | 2024 | 3135 | 0.410 |
Why?
|
Myositis | 2 | 2019 | 62 | 0.410 |
Why?
|
Pseudomonas Infections | 2 | 2009 | 115 | 0.400 |
Why?
|
Streptococcus anginosus | 2 | 2024 | 9 | 0.390 |
Why?
|
Growth Plate | 1 | 2012 | 20 | 0.380 |
Why?
|
Pneumonia, Bacterial | 4 | 2016 | 76 | 0.380 |
Why?
|
Pneumonia, Staphylococcal | 1 | 2011 | 18 | 0.370 |
Why?
|
Abscess | 3 | 2024 | 138 | 0.370 |
Why?
|
Organ Transplantation | 3 | 2016 | 165 | 0.370 |
Why?
|
Bacterial Vaccines | 6 | 2007 | 99 | 0.370 |
Why?
|
Intercellular Adhesion Molecule-1 | 3 | 1996 | 137 | 0.370 |
Why?
|
Gram-Negative Bacterial Infections | 3 | 2004 | 86 | 0.360 |
Why?
|
Ampicillin | 12 | 2004 | 57 | 0.360 |
Why?
|
Adhesins, Bacterial | 4 | 2020 | 75 | 0.360 |
Why?
|
Linezolid | 10 | 2010 | 25 | 0.360 |
Why?
|
Liver Diseases | 2 | 2008 | 365 | 0.340 |
Why?
|
Chi-Square Distribution | 7 | 2013 | 585 | 0.340 |
Why?
|
Neutropenia | 3 | 2009 | 200 | 0.340 |
Why?
|
Staphylococcus | 6 | 2019 | 70 | 0.330 |
Why?
|
Hospitalization | 6 | 2021 | 1769 | 0.330 |
Why?
|
Mupirocin | 3 | 2015 | 19 | 0.330 |
Why?
|
Cefotaxime | 10 | 2002 | 35 | 0.330 |
Why?
|
Cephalosporin Resistance | 5 | 2002 | 17 | 0.330 |
Why?
|
Citrobacter | 7 | 1992 | 21 | 0.320 |
Why?
|
Bone Diseases, Infectious | 2 | 2019 | 8 | 0.320 |
Why?
|
Drug Resistance, Multiple, Bacterial | 5 | 2016 | 134 | 0.320 |
Why?
|
Blister | 1 | 2009 | 21 | 0.310 |
Why?
|
Glucocorticoids | 2 | 2009 | 380 | 0.310 |
Why?
|
Salmonella Infections | 2 | 2019 | 31 | 0.310 |
Why?
|
Skin Diseases, Bacterial | 4 | 2014 | 23 | 0.310 |
Why?
|
Catheter-Related Infections | 1 | 2010 | 128 | 0.300 |
Why?
|
Anemia, Sickle Cell | 3 | 2019 | 334 | 0.300 |
Why?
|
Young Adult | 12 | 2019 | 8988 | 0.300 |
Why?
|
Toxocariasis | 1 | 2008 | 26 | 0.300 |
Why?
|
Tetanus Toxoid | 3 | 1994 | 45 | 0.300 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 2 | 2024 | 257 | 0.290 |
Why?
|
Recurrence | 8 | 2016 | 1421 | 0.290 |
Why?
|
Ascites | 1 | 2008 | 88 | 0.290 |
Why?
|
Cerebral Ventriculitis | 2 | 2017 | 15 | 0.290 |
Why?
|
DNA, Bacterial | 6 | 2021 | 477 | 0.280 |
Why?
|
Prosthesis-Related Infections | 2 | 2020 | 177 | 0.280 |
Why?
|
Candidiasis | 3 | 1996 | 129 | 0.280 |
Why?
|
Eosinophils | 1 | 2008 | 120 | 0.280 |
Why?
|
Respiratory Tract Infections | 4 | 2001 | 270 | 0.280 |
Why?
|
Virulence Factors | 4 | 2018 | 176 | 0.270 |
Why?
|
Moxalactam | 9 | 1988 | 21 | 0.270 |
Why?
|
Polymerase Chain Reaction | 7 | 2011 | 1585 | 0.270 |
Why?
|
Otitis Media with Effusion | 2 | 2004 | 18 | 0.270 |
Why?
|
Molecular Epidemiology | 6 | 2020 | 155 | 0.270 |
Why?
|
Drug Resistance, Multiple | 2 | 2003 | 48 | 0.270 |
Why?
|
Endocarditis, Bacterial | 2 | 2024 | 132 | 0.260 |
Why?
|
Chloramphenicol | 8 | 1993 | 29 | 0.260 |
Why?
|
Immunization Schedule | 3 | 2019 | 101 | 0.250 |
Why?
|
Enterobacteriaceae Infections | 4 | 1990 | 54 | 0.250 |
Why?
|
Leukocyte Count | 8 | 2013 | 250 | 0.240 |
Why?
|
Spleen | 3 | 2002 | 281 | 0.240 |
Why?
|
Sepsis | 9 | 2015 | 477 | 0.240 |
Why?
|
Measles | 1 | 2025 | 33 | 0.240 |
Why?
|
Magnetic Resonance Imaging | 5 | 2012 | 3547 | 0.240 |
Why?
|
Pediatrics | 2 | 2013 | 1158 | 0.240 |
Why?
|
Vaccination | 6 | 2025 | 953 | 0.230 |
Why?
|
DNA Fingerprinting | 4 | 2010 | 107 | 0.230 |
Why?
|
Exudates and Transudates | 1 | 2004 | 20 | 0.230 |
Why?
|
Venous Thrombosis | 1 | 2006 | 182 | 0.220 |
Why?
|
beta-Lactams | 1 | 2004 | 51 | 0.220 |
Why?
|
Antibiotic Prophylaxis | 2 | 2006 | 119 | 0.220 |
Why?
|
Azithromycin | 1 | 2004 | 44 | 0.220 |
Why?
|
Penicillin G | 2 | 2023 | 19 | 0.220 |
Why?
|
Cefadroxil | 1 | 2003 | 1 | 0.220 |
Why?
|
Aminoglycosides | 4 | 2018 | 45 | 0.210 |
Why?
|
Pelvis | 1 | 2024 | 71 | 0.210 |
Why?
|
Exanthema | 1 | 2004 | 69 | 0.210 |
Why?
|
Risk Factors | 14 | 2020 | 10245 | 0.210 |
Why?
|
Drug Monitoring | 1 | 2024 | 170 | 0.210 |
Why?
|
Ketolides | 1 | 2003 | 4 | 0.210 |
Why?
|
Erythromycin | 1 | 2003 | 20 | 0.210 |
Why?
|
Age Factors | 9 | 2020 | 2806 | 0.210 |
Why?
|
Salmonella | 2 | 2019 | 28 | 0.210 |
Why?
|
Prognosis | 7 | 2013 | 4608 | 0.200 |
Why?
|
Lung Diseases | 2 | 2009 | 384 | 0.200 |
Why?
|
Disease Susceptibility | 3 | 2019 | 298 | 0.200 |
Why?
|
Cell Adhesion Molecules | 1 | 2004 | 221 | 0.200 |
Why?
|
Genotype | 7 | 2018 | 2555 | 0.200 |
Why?
|
Frontal Sinusitis | 1 | 2002 | 4 | 0.200 |
Why?
|
Catheterization, Central Venous | 2 | 1994 | 130 | 0.200 |
Why?
|
Monte Carlo Method | 1 | 2023 | 95 | 0.200 |
Why?
|
E-Selectin | 2 | 2004 | 41 | 0.200 |
Why?
|
Bacterial Proteins | 7 | 2019 | 888 | 0.200 |
Why?
|
Epidural Abscess | 1 | 2002 | 11 | 0.200 |
Why?
|
Endothelium, Vascular | 2 | 1997 | 520 | 0.200 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2003 | 73 | 0.200 |
Why?
|
beta-Lactamases | 1 | 2024 | 197 | 0.200 |
Why?
|
Statistics, Nonparametric | 5 | 2013 | 427 | 0.200 |
Why?
|
Arthritis | 2 | 2019 | 81 | 0.190 |
Why?
|
Amoxicillin | 1 | 2023 | 121 | 0.190 |
Why?
|
Child, Hospitalized | 2 | 2018 | 71 | 0.190 |
Why?
|
Splenectomy | 1 | 2002 | 64 | 0.190 |
Why?
|
Bacterial Outer Membrane Proteins | 5 | 1990 | 107 | 0.190 |
Why?
|
Adult | 23 | 2015 | 29340 | 0.190 |
Why?
|
Genes, Bacterial | 2 | 2020 | 209 | 0.190 |
Why?
|
Macrophage-1 Antigen | 2 | 2001 | 26 | 0.180 |
Why?
|
Neisseria meningitidis | 3 | 2013 | 19 | 0.180 |
Why?
|
Lung Abscess | 3 | 2002 | 14 | 0.180 |
Why?
|
Meningitis, Aseptic | 1 | 2001 | 12 | 0.180 |
Why?
|
Facial Dermatoses | 1 | 2000 | 8 | 0.180 |
Why?
|
Stenotrophomonas maltophilia | 1 | 2000 | 8 | 0.180 |
Why?
|
Time Factors | 7 | 2015 | 6283 | 0.180 |
Why?
|
Drug Approval | 1 | 2021 | 42 | 0.180 |
Why?
|
Tomography, X-Ray Computed | 7 | 2008 | 2089 | 0.180 |
Why?
|
Cytarabine | 1 | 2001 | 98 | 0.180 |
Why?
|
Genome, Bacterial | 1 | 2001 | 186 | 0.180 |
Why?
|
Cefazolin | 1 | 2020 | 20 | 0.180 |
Why?
|
Blood Culture | 1 | 2020 | 31 | 0.170 |
Why?
|
Deafness | 5 | 1998 | 83 | 0.170 |
Why?
|
Immunization, Passive | 1 | 2001 | 120 | 0.170 |
Why?
|
Labyrinthitis | 3 | 1991 | 10 | 0.170 |
Why?
|
Staphylococcal Scalded Skin Syndrome | 1 | 2020 | 8 | 0.170 |
Why?
|
Diphtheria Toxoid | 2 | 1990 | 7 | 0.170 |
Why?
|
Comorbidity | 4 | 2017 | 1529 | 0.170 |
Why?
|
Hemoglobinopathies | 1 | 2019 | 16 | 0.170 |
Why?
|
Abdominal Abscess | 2 | 1998 | 24 | 0.170 |
Why?
|
Biofilms | 1 | 2020 | 92 | 0.160 |
Why?
|
Quality of Health Care | 1 | 2022 | 388 | 0.160 |
Why?
|
Escherichia coli Infections | 5 | 1995 | 196 | 0.160 |
Why?
|
Polysaccharides, Bacterial | 5 | 1992 | 68 | 0.160 |
Why?
|
Cephamycins | 4 | 1982 | 11 | 0.160 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2001 | 183 | 0.160 |
Why?
|
Genes, MDR | 1 | 2019 | 6 | 0.160 |
Why?
|
Echocardiography | 1 | 2024 | 1049 | 0.160 |
Why?
|
Prevalence | 8 | 2018 | 2445 | 0.160 |
Why?
|
Brain Diseases | 2 | 1995 | 298 | 0.160 |
Why?
|
Cerebrospinal Fluid Shunts | 2 | 2018 | 80 | 0.160 |
Why?
|
Referral and Consultation | 1 | 2022 | 542 | 0.150 |
Why?
|
Flavobacterium | 1 | 1998 | 4 | 0.150 |
Why?
|
Typhoid Fever | 1 | 1998 | 19 | 0.150 |
Why?
|
Hearing Loss | 3 | 2009 | 134 | 0.150 |
Why?
|
Orbital Cellulitis | 1 | 2018 | 14 | 0.150 |
Why?
|
Bone Marrow Transplantation | 1 | 2001 | 575 | 0.150 |
Why?
|
Ibuprofen | 1 | 1998 | 41 | 0.150 |
Why?
|
Bacterial Adhesion | 4 | 1993 | 105 | 0.150 |
Why?
|
Prostheses and Implants | 1 | 2019 | 151 | 0.150 |
Why?
|
Hearing Loss, Bilateral | 2 | 1997 | 16 | 0.150 |
Why?
|
Follow-Up Studies | 9 | 2020 | 5129 | 0.150 |
Why?
|
Cytokines | 1 | 2004 | 1289 | 0.150 |
Why?
|
Administration, Oral | 7 | 2018 | 681 | 0.150 |
Why?
|
Labyrinth Diseases | 2 | 1989 | 6 | 0.150 |
Why?
|
Pandemics | 2 | 2022 | 1096 | 0.150 |
Why?
|
Bacterial Capsules | 3 | 2016 | 37 | 0.140 |
Why?
|
Immunoglobulin G | 3 | 2012 | 776 | 0.140 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1998 | 71 | 0.140 |
Why?
|
Hospitals | 2 | 2011 | 389 | 0.140 |
Why?
|
Drainage | 3 | 2010 | 257 | 0.140 |
Why?
|
Bacteriological Techniques | 2 | 2016 | 87 | 0.140 |
Why?
|
Nervous System Diseases | 3 | 1995 | 374 | 0.140 |
Why?
|
P-Selectin | 1 | 1997 | 78 | 0.140 |
Why?
|
Immunogenicity, Vaccine | 1 | 2018 | 102 | 0.140 |
Why?
|
Prostatic Diseases | 1 | 2017 | 15 | 0.140 |
Why?
|
Acetaminophen | 1 | 1998 | 94 | 0.140 |
Why?
|
Age Distribution | 4 | 2010 | 414 | 0.140 |
Why?
|
Virulence | 4 | 2005 | 262 | 0.130 |
Why?
|
Animals | 20 | 2019 | 34040 | 0.130 |
Why?
|
Students | 1 | 2019 | 248 | 0.130 |
Why?
|
Diarrhea | 1 | 2018 | 317 | 0.130 |
Why?
|
Brucella melitensis | 1 | 1996 | 8 | 0.130 |
Why?
|
Oxazoles | 1 | 1996 | 23 | 0.130 |
Why?
|
Brucellosis | 1 | 1996 | 19 | 0.130 |
Why?
|
Enterococcus | 2 | 2019 | 29 | 0.130 |
Why?
|
Probability | 4 | 2005 | 322 | 0.130 |
Why?
|
Electronic Health Records | 2 | 2019 | 722 | 0.130 |
Why?
|
Penicillanic Acid | 1 | 2015 | 9 | 0.130 |
Why?
|
Radiography, Interventional | 1 | 2016 | 87 | 0.120 |
Why?
|
Mice, Mutant Strains | 4 | 1997 | 383 | 0.120 |
Why?
|
Whipple Disease | 1 | 1995 | 6 | 0.120 |
Why?
|
Streptococcus | 2 | 2015 | 61 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2018 | 368 | 0.120 |
Why?
|
Bacteria, Anaerobic | 1 | 1995 | 9 | 0.120 |
Why?
|
Clostridium Infections | 1 | 2018 | 245 | 0.120 |
Why?
|
Disease Management | 3 | 2019 | 518 | 0.120 |
Why?
|
Epidemiological Monitoring | 1 | 2015 | 59 | 0.120 |
Why?
|
Severity of Illness Index | 6 | 2010 | 2882 | 0.120 |
Why?
|
Cluster Analysis | 3 | 2011 | 397 | 0.110 |
Why?
|
Staphylococcus epidermidis | 2 | 1993 | 39 | 0.110 |
Why?
|
Infection Control | 1 | 2015 | 154 | 0.110 |
Why?
|
Prostate | 1 | 2017 | 435 | 0.110 |
Why?
|
Lung Transplantation | 2 | 2009 | 320 | 0.110 |
Why?
|
Risk Assessment | 6 | 2012 | 3430 | 0.110 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1994 | 15 | 0.110 |
Why?
|
Cats | 2 | 2008 | 117 | 0.110 |
Why?
|
Rhizopus | 1 | 1993 | 10 | 0.110 |
Why?
|
Intestines | 1 | 1998 | 573 | 0.110 |
Why?
|
Bridged Bicyclo Compounds, Heterocyclic | 1 | 2014 | 39 | 0.110 |
Why?
|
Tetanus | 1 | 1994 | 21 | 0.110 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 779 | 0.110 |
Why?
|
Hearing Loss, Sensorineural | 4 | 1995 | 141 | 0.110 |
Why?
|
Eczema | 1 | 2013 | 29 | 0.110 |
Why?
|
Drug Administration Schedule | 5 | 2018 | 722 | 0.110 |
Why?
|
Necrosis | 3 | 2002 | 208 | 0.110 |
Why?
|
Mucormycosis | 1 | 1993 | 27 | 0.110 |
Why?
|
Mycobacterium Infections, Nontuberculous | 2 | 2009 | 46 | 0.110 |
Why?
|
Antibodies, Monoclonal | 2 | 1997 | 1018 | 0.110 |
Why?
|
Infusions, Intravenous | 5 | 2016 | 547 | 0.110 |
Why?
|
Single-Blind Method | 1 | 2013 | 231 | 0.100 |
Why?
|
Nasal Cavity | 2 | 2011 | 50 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 317 | 0.100 |
Why?
|
Ticarcillin | 2 | 2009 | 8 | 0.100 |
Why?
|
Down Syndrome | 1 | 2015 | 197 | 0.100 |
Why?
|
Clinical Trials as Topic | 7 | 2002 | 1085 | 0.100 |
Why?
|
Drug Synergism | 4 | 1998 | 227 | 0.100 |
Why?
|
Gentamicins | 4 | 2009 | 95 | 0.100 |
Why?
|
Fimbriae, Bacterial | 6 | 1992 | 42 | 0.100 |
Why?
|
Outpatients | 2 | 2024 | 251 | 0.100 |
Why?
|
Antibodies, Catalytic | 1 | 2012 | 7 | 0.100 |
Why?
|
Cefuroxime | 4 | 2001 | 15 | 0.100 |
Why?
|
Epidemiologic Studies | 2 | 2002 | 43 | 0.100 |
Why?
|
Empyema, Pleural | 2 | 2004 | 24 | 0.100 |
Why?
|
Pleural Effusion | 3 | 2004 | 102 | 0.100 |
Why?
|
Fractures, Spontaneous | 1 | 2012 | 18 | 0.100 |
Why?
|
Gadolinium DTPA | 1 | 2012 | 47 | 0.100 |
Why?
|
Career Choice | 1 | 2013 | 145 | 0.100 |
Why?
|
Molecular Typing | 1 | 2011 | 34 | 0.090 |
Why?
|
Radiography | 5 | 2004 | 821 | 0.090 |
Why?
|
Proteolysis | 1 | 2012 | 170 | 0.090 |
Why?
|
Sensitivity and Specificity | 3 | 2012 | 2041 | 0.090 |
Why?
|
Drug Resistance | 2 | 2021 | 255 | 0.090 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2023 | 1688 | 0.090 |
Why?
|
Encephalitis | 2 | 2008 | 109 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2012 | 198 | 0.090 |
Why?
|
Cystic Fibrosis | 2 | 2009 | 257 | 0.090 |
Why?
|
Virus Diseases | 2 | 2011 | 280 | 0.090 |
Why?
|
Rats | 8 | 1997 | 3676 | 0.090 |
Why?
|
Synovial Fluid | 1 | 2009 | 15 | 0.080 |
Why?
|
Public Health Surveillance | 2 | 2020 | 38 | 0.080 |
Why?
|
Lipopolysaccharides | 2 | 1988 | 292 | 0.080 |
Why?
|
Vaccines, Synthetic | 1 | 1990 | 317 | 0.080 |
Why?
|
Clavulanic Acid | 1 | 2009 | 6 | 0.080 |
Why?
|
Nontuberculous Mycobacteria | 1 | 2009 | 25 | 0.080 |
Why?
|
Infant, Premature | 4 | 2007 | 813 | 0.080 |
Why?
|
Infant, Low Birth Weight | 4 | 1993 | 167 | 0.080 |
Why?
|
Anemia | 2 | 2003 | 340 | 0.080 |
Why?
|
Cochlea | 1 | 1989 | 85 | 0.080 |
Why?
|
Thigh | 1 | 2009 | 51 | 0.080 |
Why?
|
Technetium Tc 99m Medronate | 1 | 2008 | 3 | 0.080 |
Why?
|
Toxocara | 1 | 2008 | 10 | 0.080 |
Why?
|
Diagnosis, Differential | 5 | 2011 | 1878 | 0.070 |
Why?
|
Leukocytosis | 2 | 2000 | 46 | 0.070 |
Why?
|
Albendazole | 1 | 2008 | 29 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2016 | 1198 | 0.070 |
Why?
|
Temporal Bone | 1 | 2008 | 36 | 0.070 |
Why?
|
Vasopressins | 2 | 1978 | 43 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2009 | 355 | 0.070 |
Why?
|
Contrast Media | 1 | 2012 | 470 | 0.070 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2008 | 106 | 0.070 |
Why?
|
Anthelmintics | 1 | 2008 | 55 | 0.070 |
Why?
|
Heptavalent Pneumococcal Conjugate Vaccine | 2 | 2006 | 25 | 0.070 |
Why?
|
Kinetics | 7 | 1992 | 1321 | 0.070 |
Why?
|
Coagulase | 3 | 2018 | 24 | 0.070 |
Why?
|
Organophosphonates | 1 | 2007 | 19 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2012 | 2862 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 1421 | 0.070 |
Why?
|
Cytosine | 1 | 2007 | 56 | 0.070 |
Why?
|
Complement Factor H | 1 | 2007 | 21 | 0.070 |
Why?
|
Adenovirus Infections, Human | 1 | 2007 | 50 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2008 | 216 | 0.070 |
Why?
|
Receptors, Complement | 1 | 2007 | 32 | 0.070 |
Why?
|
Sex Distribution | 2 | 2010 | 302 | 0.070 |
Why?
|
Amphotericin B | 1 | 1987 | 90 | 0.070 |
Why?
|
Paresis | 1 | 1986 | 35 | 0.070 |
Why?
|
Cohort Studies | 4 | 2016 | 4780 | 0.070 |
Why?
|
Nasopharynx | 2 | 1990 | 79 | 0.070 |
Why?
|
Antigens, Bacterial | 3 | 2007 | 314 | 0.070 |
Why?
|
Fever of Unknown Origin | 2 | 1996 | 45 | 0.060 |
Why?
|
Leukocytes | 2 | 1997 | 204 | 0.060 |
Why?
|
Haemophilus parainfluenzae | 1 | 2005 | 11 | 0.060 |
Why?
|
Africa | 1 | 2006 | 132 | 0.060 |
Why?
|
Morbidity | 1 | 2006 | 246 | 0.060 |
Why?
|
Peptides, Cyclic | 1 | 2005 | 52 | 0.060 |
Why?
|
Measles Vaccine | 1 | 2025 | 10 | 0.060 |
Why?
|
Membrane Transport Proteins | 2 | 2019 | 176 | 0.060 |
Why?
|
Middle Aged | 6 | 2015 | 26589 | 0.060 |
Why?
|
Encephalitis, St. Louis | 1 | 2004 | 20 | 0.060 |
Why?
|
Antiviral Agents | 2 | 2007 | 746 | 0.060 |
Why?
|
Infant, Premature, Diseases | 1 | 1987 | 242 | 0.060 |
Why?
|
Thrombocytopenia | 2 | 2003 | 221 | 0.060 |
Why?
|
Hearing Loss, Central | 1 | 1984 | 3 | 0.060 |
Why?
|
Communicable Diseases, Emerging | 1 | 2005 | 63 | 0.060 |
Why?
|
Blood Platelets | 1 | 1987 | 327 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2019 | 3266 | 0.060 |
Why?
|
Etoposide | 1 | 2004 | 114 | 0.060 |
Why?
|
Databases, Factual | 2 | 2019 | 1173 | 0.060 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2004 | 54 | 0.060 |
Why?
|
Survival Analysis | 3 | 2001 | 1491 | 0.060 |
Why?
|
Lactams | 1 | 2004 | 14 | 0.060 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2004 | 62 | 0.050 |
Why?
|
Musculoskeletal Diseases | 1 | 2004 | 57 | 0.050 |
Why?
|
Cyclosporine | 1 | 2004 | 146 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2006 | 178 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2004 | 99 | 0.050 |
Why?
|
Latin America | 1 | 2003 | 92 | 0.050 |
Why?
|
Global Health | 2 | 2021 | 559 | 0.050 |
Why?
|
Interleukin-2 | 1 | 2004 | 225 | 0.050 |
Why?
|
Fluoroquinolones | 1 | 2004 | 93 | 0.050 |
Why?
|
Subdural Effusion | 3 | 1992 | 8 | 0.050 |
Why?
|
Antifungal Agents | 1 | 2005 | 288 | 0.050 |
Why?
|
Cell Movement | 2 | 1997 | 834 | 0.050 |
Why?
|
Abdominal Pain | 1 | 2005 | 309 | 0.050 |
Why?
|
Nafcillin | 2 | 1982 | 14 | 0.050 |
Why?
|
Treatment Failure | 1 | 2004 | 338 | 0.050 |
Why?
|
Confidence Intervals | 1 | 2003 | 284 | 0.050 |
Why?
|
Cerebrospinal Fluid | 2 | 2000 | 94 | 0.050 |
Why?
|
Length of Stay | 4 | 2018 | 1303 | 0.050 |
Why?
|
Internship and Residency | 1 | 2013 | 1179 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2002 | 4343 | 0.050 |
Why?
|
Mice | 6 | 2012 | 17622 | 0.050 |
Why?
|
Sex Factors | 1 | 2006 | 1277 | 0.050 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2003 | 144 | 0.050 |
Why?
|
Empyema | 1 | 2002 | 23 | 0.050 |
Why?
|
Health Planning Guidelines | 1 | 2002 | 32 | 0.050 |
Why?
|
Diseases in Twins | 1 | 1983 | 94 | 0.050 |
Why?
|
Microscopy, Electron | 5 | 1992 | 393 | 0.050 |
Why?
|
Siblings | 1 | 2003 | 197 | 0.050 |
Why?
|
Age of Onset | 1 | 2003 | 585 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2007 | 370 | 0.050 |
Why?
|
Interleukin-6 | 1 | 2004 | 419 | 0.050 |
Why?
|
Picornaviridae | 1 | 1981 | 20 | 0.050 |
Why?
|
Craniotomy | 1 | 2002 | 108 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2002 | 276 | 0.050 |
Why?
|
Aspirin | 1 | 2003 | 224 | 0.050 |
Why?
|
Serologic Tests | 1 | 2002 | 118 | 0.050 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2001 | 26 | 0.050 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 577 | 0.050 |
Why?
|
Opsonin Proteins | 1 | 1981 | 20 | 0.050 |
Why?
|
Streptococcus pyogenes | 1 | 2021 | 77 | 0.050 |
Why?
|
Immunologic Techniques | 1 | 1980 | 12 | 0.050 |
Why?
|
Thrombosis | 2 | 1997 | 518 | 0.040 |
Why?
|
Neoplasms | 2 | 2013 | 2765 | 0.040 |
Why?
|
Causality | 1 | 2000 | 83 | 0.040 |
Why?
|
Mortality | 1 | 2002 | 237 | 0.040 |
Why?
|
Rats, Inbred Strains | 4 | 1991 | 232 | 0.040 |
Why?
|
Species Specificity | 4 | 1998 | 549 | 0.040 |
Why?
|
Pott Puffy Tumor | 1 | 2020 | 3 | 0.040 |
Why?
|
Hearing Disorders | 2 | 1990 | 25 | 0.040 |
Why?
|
HIV Infections | 1 | 2012 | 1891 | 0.040 |
Why?
|
Central Nervous System Infections | 1 | 2020 | 21 | 0.040 |
Why?
|
Haemophilus influenzae type b | 1 | 1999 | 5 | 0.040 |
Why?
|
Ataxia | 1 | 1981 | 168 | 0.040 |
Why?
|
Cerebrospinal Fluid Proteins | 4 | 1990 | 22 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2003 | 1629 | 0.040 |
Why?
|
Spinal Puncture | 1 | 1999 | 52 | 0.040 |
Why?
|
Bone Diseases | 1 | 2019 | 43 | 0.040 |
Why?
|
Consciousness | 1 | 1999 | 49 | 0.040 |
Why?
|
Neisseriaceae Infections | 1 | 1999 | 2 | 0.040 |
Why?
|
Kingella kingae | 1 | 1999 | 2 | 0.040 |
Why?
|
Antiporters | 1 | 2019 | 32 | 0.040 |
Why?
|
Flaviviridae | 1 | 1999 | 5 | 0.040 |
Why?
|
Erythema Infectiosum | 1 | 1999 | 8 | 0.040 |
Why?
|
Chlamydophila pneumoniae | 1 | 1999 | 11 | 0.040 |
Why?
|
Ehrlichiosis | 1 | 1999 | 10 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2012 | 3872 | 0.040 |
Why?
|
Hantavirus Infections | 1 | 1999 | 7 | 0.040 |
Why?
|
Biopsy | 1 | 2003 | 1237 | 0.040 |
Why?
|
Enterobacter cloacae | 1 | 2018 | 12 | 0.040 |
Why?
|
Microbiological Techniques | 1 | 1999 | 31 | 0.040 |
Why?
|
Pentosephosphates | 2 | 1992 | 8 | 0.040 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2003 | 450 | 0.040 |
Why?
|
Medical Records | 1 | 2019 | 189 | 0.040 |
Why?
|
Hepatitis, Viral, Human | 1 | 1999 | 44 | 0.040 |
Why?
|
Chlamydia Infections | 1 | 1999 | 49 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2019 | 286 | 0.040 |
Why?
|
Enema | 1 | 1998 | 39 | 0.040 |
Why?
|
Hypoxia, Brain | 1 | 1978 | 34 | 0.040 |
Why?
|
Pneumonia, Aspiration | 1 | 1978 | 18 | 0.040 |
Why?
|
Amikacin | 3 | 1993 | 24 | 0.040 |
Why?
|
Herpesviridae Infections | 1 | 1999 | 142 | 0.040 |
Why?
|
Hydrocephalus | 2 | 1992 | 245 | 0.040 |
Why?
|
Judgment | 1 | 2017 | 36 | 0.040 |
Why?
|
Skin | 1 | 2020 | 516 | 0.030 |
Why?
|
Patient Selection | 1 | 2021 | 689 | 0.030 |
Why?
|
Fusobacterium | 1 | 2016 | 4 | 0.030 |
Why?
|
Fusobacterium Infections | 1 | 2016 | 14 | 0.030 |
Why?
|
Intestinal Obstruction | 1 | 1998 | 94 | 0.030 |
Why?
|
Patient Admission | 1 | 2018 | 185 | 0.030 |
Why?
|
Foreign Bodies | 1 | 1978 | 104 | 0.030 |
Why?
|
Phagocytes | 1 | 1996 | 23 | 0.030 |
Why?
|
Central Nervous System | 1 | 2018 | 251 | 0.030 |
Why?
|
Hypotension | 1 | 1998 | 184 | 0.030 |
Why?
|
Fungemia | 1 | 1996 | 22 | 0.030 |
Why?
|
Lung | 2 | 2009 | 1487 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 1996 | 21 | 0.030 |
Why?
|
Oxacillin | 1 | 1995 | 6 | 0.030 |
Why?
|
Antibiotics, Antitubercular | 1 | 1996 | 33 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 1104 | 0.030 |
Why?
|
Aged | 5 | 2015 | 19533 | 0.030 |
Why?
|
Mycobacterium chelonae | 1 | 1995 | 6 | 0.030 |
Why?
|
Seizures | 2 | 1992 | 874 | 0.030 |
Why?
|
Epithelium | 3 | 1992 | 362 | 0.030 |
Why?
|
Piperacillin | 1 | 2015 | 13 | 0.030 |
Why?
|
beta-Lactam Resistance | 1 | 1996 | 47 | 0.030 |
Why?
|
Ambulatory Care | 1 | 1998 | 385 | 0.030 |
Why?
|
Brain | 2 | 1996 | 2980 | 0.030 |
Why?
|
Bacteria, Aerobic | 1 | 1995 | 1 | 0.030 |
Why?
|
Meninges | 1 | 1995 | 18 | 0.030 |
Why?
|
Total Quality Management | 1 | 1995 | 24 | 0.030 |
Why?
|
Twins | 1 | 2015 | 69 | 0.030 |
Why?
|
Feces | 1 | 2018 | 724 | 0.030 |
Why?
|
Eye Infections, Bacterial | 1 | 1995 | 92 | 0.030 |
Why?
|
Ischemia | 1 | 1978 | 354 | 0.030 |
Why?
|
Orbital Diseases | 1 | 1995 | 91 | 0.030 |
Why?
|
Genomics | 1 | 2022 | 1492 | 0.030 |
Why?
|
Electrophoresis | 1 | 1994 | 47 | 0.030 |
Why?
|
Kidney | 2 | 1996 | 1354 | 0.030 |
Why?
|
Random Allocation | 2 | 1988 | 436 | 0.030 |
Why?
|
Animals, Newborn | 4 | 1991 | 1006 | 0.030 |
Why?
|
Diterpenes | 1 | 2014 | 28 | 0.030 |
Why?
|
Diphtheria | 1 | 1994 | 15 | 0.030 |
Why?
|
Diffusion | 1 | 1993 | 57 | 0.030 |
Why?
|
Iliac Vein | 1 | 1994 | 34 | 0.030 |
Why?
|
Drug Implants | 1 | 1993 | 42 | 0.030 |
Why?
|
Blood | 1 | 2014 | 104 | 0.030 |
Why?
|
Femoral Vein | 1 | 1994 | 50 | 0.030 |
Why?
|
Critical Care | 1 | 1999 | 656 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 1231 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 1995 | 356 | 0.030 |
Why?
|
Whooping Cough | 1 | 1994 | 58 | 0.030 |
Why?
|
Disease Progression | 1 | 1999 | 2043 | 0.030 |
Why?
|
Blood Cell Count | 2 | 2002 | 69 | 0.030 |
Why?
|
Meningocele | 1 | 1993 | 19 | 0.030 |
Why?
|
Specific Pathogen-Free Organisms | 2 | 1991 | 52 | 0.030 |
Why?
|
Dermoid Cyst | 1 | 1993 | 34 | 0.030 |
Why?
|
Heart Defects, Congenital | 1 | 2024 | 1813 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 341 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 2 | 1986 | 457 | 0.030 |
Why?
|
Umbilical Veins | 1 | 1992 | 73 | 0.030 |
Why?
|
Blood Pressure | 1 | 1998 | 1350 | 0.030 |
Why?
|
Weight Loss | 1 | 1996 | 480 | 0.020 |
Why?
|
Endoscopy | 1 | 2014 | 281 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1993 | 212 | 0.020 |
Why?
|
Cerebral Ventricles | 2 | 1990 | 81 | 0.020 |
Why?
|
Glycemic Index | 1 | 2012 | 19 | 0.020 |
Why?
|
Drug Combinations | 1 | 1993 | 268 | 0.020 |
Why?
|
Meningoencephalitis | 2 | 2001 | 18 | 0.020 |
Why?
|
Quinine | 1 | 2012 | 7 | 0.020 |
Why?
|
Klebsiella Infections | 2 | 1990 | 54 | 0.020 |
Why?
|
Otitis | 1 | 2012 | 11 | 0.020 |
Why?
|
Empyema, Subdural | 1 | 1992 | 9 | 0.020 |
Why?
|
Meningitis, Listeria | 2 | 1988 | 2 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1995 | 680 | 0.020 |
Why?
|
RNA, Bacterial | 1 | 2012 | 54 | 0.020 |
Why?
|
Base Sequence | 2 | 2007 | 3089 | 0.020 |
Why?
|
Genes, Essential | 1 | 2012 | 40 | 0.020 |
Why?
|
Pentoxifylline | 1 | 1991 | 20 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 231 | 0.020 |
Why?
|
Hemoglobins | 2 | 2003 | 303 | 0.020 |
Why?
|
Hypothalamic Diseases | 1 | 1992 | 37 | 0.020 |
Why?
|
Ultrasonography | 1 | 1996 | 931 | 0.020 |
Why?
|
Clavulanic Acids | 1 | 1991 | 2 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 89 | 0.020 |
Why?
|
Premedication | 1 | 1991 | 43 | 0.020 |
Why?
|
Pregnancy | 1 | 2003 | 7175 | 0.020 |
Why?
|
Enterobacter | 1 | 1990 | 14 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1992 | 1058 | 0.020 |
Why?
|
Vancomycin Resistance | 1 | 2010 | 21 | 0.020 |
Why?
|
Immunization | 2 | 1991 | 307 | 0.020 |
Why?
|
Intestinal Perforation | 1 | 1991 | 57 | 0.020 |
Why?
|
Liver | 1 | 1997 | 1733 | 0.020 |
Why?
|
Immunization, Secondary | 1 | 1990 | 103 | 0.020 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2012 | 370 | 0.020 |
Why?
|
Chronic Disease | 1 | 2014 | 1179 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2011 | 231 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 2 | 1982 | 169 | 0.020 |
Why?
|
beta-Lactamase Inhibitors | 1 | 1991 | 59 | 0.020 |
Why?
|
Bronchodilator Agents | 1 | 1991 | 153 | 0.020 |
Why?
|
Viral Load | 1 | 2012 | 384 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2012 | 757 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 1995 | 2392 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2011 | 6465 | 0.020 |
Why?
|
Ceftazidime | 1 | 1990 | 43 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 1992 | 283 | 0.020 |
Why?
|
Phylogeny | 1 | 2012 | 694 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2012 | 1001 | 0.020 |
Why?
|
Arginine Vasopressin | 2 | 1981 | 28 | 0.020 |
Why?
|
Appendicitis | 1 | 1991 | 126 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 313 | 0.020 |
Why?
|
Erythrocytes | 1 | 1990 | 212 | 0.020 |
Why?
|
Sputum | 1 | 2009 | 106 | 0.020 |
Why?
|
Models, Biological | 1 | 1993 | 1454 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 1991 | 259 | 0.020 |
Why?
|
Tomography, Emission-Computed | 1 | 1988 | 43 | 0.020 |
Why?
|
Nephritis | 1 | 1988 | 20 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 1988 | 134 | 0.020 |
Why?
|
Phenotype | 3 | 2007 | 4249 | 0.020 |
Why?
|
Streptococcus agalactiae | 1 | 1988 | 104 | 0.020 |
Why?
|
Genomic Islands | 1 | 2007 | 29 | 0.020 |
Why?
|
Complement Pathway, Alternative | 1 | 1987 | 14 | 0.020 |
Why?
|
Hemolysin Proteins | 1 | 1988 | 32 | 0.020 |
Why?
|
Complement Activation | 1 | 1987 | 52 | 0.020 |
Why?
|
Penicillinase | 1 | 1987 | 2 | 0.020 |
Why?
|
Hydrolases | 1 | 2007 | 54 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 161 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1992 | 662 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2012 | 2697 | 0.020 |
Why?
|
Polysaccharides | 1 | 1988 | 140 | 0.020 |
Why?
|
Bleeding Time | 1 | 1987 | 8 | 0.020 |
Why?
|
Immune Sera | 1 | 2007 | 95 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2007 | 210 | 0.020 |
Why?
|
Molecular Weight | 2 | 1985 | 390 | 0.020 |
Why?
|
Vaccines, DNA | 1 | 2007 | 48 | 0.020 |
Why?
|
Risk | 1 | 2009 | 754 | 0.020 |
Why?
|
Body Fluids | 1 | 1987 | 47 | 0.020 |
Why?
|
Platelet Count | 1 | 1987 | 136 | 0.020 |
Why?
|
Cells, Cultured | 1 | 1992 | 3037 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 1987 | 120 | 0.020 |
Why?
|
Plasmids | 1 | 2007 | 510 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1987 | 382 | 0.020 |
Why?
|
Psychological Tests | 1 | 1986 | 90 | 0.020 |
Why?
|
Organ Culture Techniques | 2 | 2001 | 155 | 0.020 |
Why?
|
Rickettsiaceae Infections | 1 | 1986 | 2 | 0.020 |
Why?
|
Cochlear Duct | 1 | 1986 | 5 | 0.020 |
Why?
|
Boutonneuse Fever | 1 | 1986 | 2 | 0.020 |
Why?
|
Organ of Corti | 1 | 1986 | 26 | 0.020 |
Why?
|
Luminescent Measurements | 2 | 1987 | 57 | 0.020 |
Why?
|
Blotting, Western | 1 | 1988 | 1102 | 0.020 |
Why?
|
Lipopeptides | 1 | 2005 | 33 | 0.020 |
Why?
|
Body Surface Area | 1 | 2005 | 31 | 0.020 |
Why?
|
Echinocandins | 1 | 2005 | 44 | 0.020 |
Why?
|
Sampling Studies | 1 | 2005 | 76 | 0.020 |
Why?
|
Encephalitis Virus, St. Louis | 1 | 2004 | 18 | 0.010 |
Why?
|
Acyclovir | 1 | 2004 | 45 | 0.010 |
Why?
|
Clone Cells | 1 | 2005 | 166 | 0.010 |
Why?
|
Audiometry, Evoked Response | 1 | 1984 | 3 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2008 | 632 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 811 | 0.010 |
Why?
|
Intellectual Disability | 1 | 1992 | 1054 | 0.010 |
Why?
|
Practice Guidelines as Topic | 3 | 1996 | 1264 | 0.010 |
Why?
|
Evoked Potentials, Auditory | 1 | 1984 | 53 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 1993 | 1210 | 0.010 |
Why?
|
Immune Adherence Reaction | 1 | 1983 | 7 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 2002 | 1228 | 0.010 |
Why?
|
Demography | 1 | 2004 | 239 | 0.010 |
Why?
|
Brain Stem | 1 | 1984 | 115 | 0.010 |
Why?
|
Macrolides | 1 | 2003 | 29 | 0.010 |
Why?
|
Practice Patterns, Physicians' | 2 | 2002 | 726 | 0.010 |
Why?
|
Syndrome | 2 | 1993 | 1119 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 1988 | 712 | 0.010 |
Why?
|
Escherichia coli | 1 | 1988 | 985 | 0.010 |
Why?
|
Gram-Negative Bacteria | 2 | 1998 | 68 | 0.010 |
Why?
|
Pharmacogenetics | 1 | 2003 | 184 | 0.010 |
Why?
|
Hemorrhage | 1 | 1986 | 467 | 0.010 |
Why?
|
Middle Ear Ventilation | 1 | 2002 | 29 | 0.010 |
Why?
|
Fluid Therapy | 1 | 1983 | 125 | 0.010 |
Why?
|
Methods | 2 | 1979 | 149 | 0.010 |
Why?
|
Mycoses | 1 | 1983 | 117 | 0.010 |
Why?
|
Reference Values | 1 | 2003 | 711 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 1982 | 52 | 0.010 |
Why?
|
Injections, Intravenous | 1 | 1982 | 253 | 0.010 |
Why?
|
Electronystagmography | 1 | 1981 | 2 | 0.010 |
Why?
|
Caloric Tests | 1 | 1981 | 7 | 0.010 |
Why?
|
Ascitic Fluid | 1 | 2001 | 30 | 0.010 |
Why?
|
Picornaviridae Infections | 1 | 1981 | 48 | 0.010 |
Why?
|
Counterimmunoelectrophoresis | 1 | 1980 | 4 | 0.010 |
Why?
|
Agglutination Tests | 1 | 1980 | 9 | 0.010 |
Why?
|
Latex Fixation Tests | 1 | 1980 | 5 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1980 | 30 | 0.010 |
Why?
|
Radioimmunoassay | 2 | 1978 | 107 | 0.010 |
Why?
|
Biological Assay | 1 | 1981 | 102 | 0.010 |
Why?
|
Genetic Variation | 1 | 2007 | 1492 | 0.010 |
Why?
|
Inpatients | 1 | 2004 | 492 | 0.010 |
Why?
|
Blood-Brain Barrier | 1 | 1981 | 142 | 0.010 |
Why?
|
Consensus | 1 | 2002 | 638 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1980 | 822 | 0.010 |
Why?
|
Punctures | 1 | 1978 | 55 | 0.010 |
Why?
|
Needles | 1 | 1978 | 51 | 0.010 |
Why?
|
Bilirubin | 1 | 1979 | 123 | 0.010 |
Why?
|
Sulbactam | 1 | 1998 | 5 | 0.010 |
Why?
|
Tobramycin | 1 | 1998 | 23 | 0.010 |
Why?
|
Asphyxia Neonatorum | 1 | 1978 | 15 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 2004 | 1151 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2004 | 1748 | 0.010 |
Why?
|
Brain Edema | 1 | 1978 | 68 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 1606 | 0.010 |
Why?
|
In Vitro Techniques | 2 | 1989 | 970 | 0.010 |
Why?
|
Hyponatremia | 1 | 1978 | 72 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 1976 | 149 | 0.010 |
Why?
|
Cheek | 2 | 1989 | 26 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1983 | 1529 | 0.010 |
Why?
|
Birth Weight | 2 | 1990 | 346 | 0.010 |
Why?
|
Vegetables | 1 | 1978 | 261 | 0.010 |
Why?
|
Eye Injuries, Penetrating | 1 | 1995 | 19 | 0.010 |
Why?
|
Laparotomy | 1 | 1976 | 135 | 0.010 |
Why?
|
Clarithromycin | 1 | 1995 | 125 | 0.010 |
Why?
|
Orbit | 1 | 1995 | 102 | 0.010 |
Why?
|
Eyelids | 1 | 1995 | 119 | 0.010 |
Why?
|
Half-Life | 2 | 1985 | 158 | 0.010 |
Why?
|
Adhesiveness | 2 | 1985 | 12 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2001 | 3726 | 0.010 |
Why?
|
Magnesium Deficiency | 1 | 1972 | 10 | 0.010 |
Why?
|
Parathyroid Glands | 1 | 1972 | 28 | 0.010 |
Why?
|
Child Development | 1 | 1995 | 266 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2001 | 4401 | 0.010 |
Why?
|
Culture Media | 1 | 1992 | 183 | 0.010 |
Why?
|
Ear, Inner | 1 | 1991 | 50 | 0.010 |
Why?
|
Ampicillin Resistance | 1 | 1991 | 17 | 0.010 |
Why?
|
Epiglottitis | 1 | 1991 | 12 | 0.010 |
Why?
|
Rupture, Spontaneous | 1 | 1991 | 47 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1991 | 107 | 0.010 |
Why?
|
Transillumination | 1 | 1990 | 4 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 1990 | 21 | 0.010 |
Why?
|
Hemadsorption | 1 | 1990 | 3 | 0.010 |
Why?
|
Appendectomy | 1 | 1991 | 86 | 0.010 |
Why?
|
Bacteriophage Typing | 1 | 1989 | 2 | 0.010 |
Why?
|
Neurologic Examination | 1 | 1990 | 194 | 0.010 |
Why?
|
Intelligence | 1 | 1990 | 98 | 0.010 |
Why?
|
Mucous Membrane | 1 | 1990 | 88 | 0.010 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 1993 | 503 | 0.000 |
Why?
|
Lymphocytes | 1 | 1990 | 406 | 0.000 |
Why?
|
Pyuria | 1 | 1988 | 6 | 0.000 |
Why?
|
Monocytes | 1 | 1990 | 351 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1990 | 796 | 0.000 |
Why?
|
Salmonella typhimurium | 1 | 1987 | 43 | 0.000 |
Why?
|
Daptomycin | 1 | 1987 | 13 | 0.000 |
Why?
|
Hemolysis | 1 | 1987 | 111 | 0.000 |
Why?
|
Bacteriuria | 1 | 1988 | 82 | 0.000 |
Why?
|
Phagocytosis | 1 | 1987 | 169 | 0.000 |
Why?
|
Gestational Age | 1 | 1990 | 1159 | 0.000 |
Why?
|
Rickettsia | 1 | 1986 | 13 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1988 | 1008 | 0.000 |
Why?
|
Glucose | 1 | 1990 | 879 | 0.000 |
Why?
|
Carbohydrates | 1 | 1985 | 34 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1985 | 100 | 0.000 |
Why?
|
Travel | 1 | 1986 | 116 | 0.000 |
Why?
|
beta 2-Microglobulin | 1 | 1984 | 34 | 0.000 |
Why?
|
Peptides | 1 | 1987 | 793 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1984 | 128 | 0.000 |
Why?
|
Pharynx | 1 | 1982 | 64 | 0.000 |
Why?
|
Nasal Mucosa | 1 | 1982 | 65 | 0.000 |
Why?
|
Temperature | 1 | 1982 | 303 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1982 | 430 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 1988 | 1083 | 0.000 |
Why?
|
Charcoal | 1 | 1979 | 6 | 0.000 |
Why?
|
Spectrophotometry | 1 | 1979 | 59 | 0.000 |
Why?
|
Parathyroid Hormone | 1 | 1972 | 73 | 0.000 |
Why?
|
Magnesium | 1 | 1972 | 120 | 0.000 |
Why?
|
Phosphates | 1 | 1972 | 113 | 0.000 |
Why?
|
Calcium | 1 | 1972 | 1099 | 0.000 |
Why?
|